SCM Pharma appoints new director
pharmafile | May 30, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | SCM Pharma
UK-based contract development and manufacturing organisation SCM Pharma has strengthened its senior management team by recruiting a director.
Paul Bradley joins the specialist manufacturer as operations director and will also sit on the company’s Board. Formally of Hospira Aseptic Services, he will now be responsible for all operational activities at SCM Pharma including production, warehouse and facilities.
Bradley brings experience of clinical trial and commercial manufacturing involving sterile products. He is the latest in a string of new senior appointments by the organisation who added Mark Edwards as Quality Assurance director earlier this year.
Dianne Sharp, managing director at SCM Pharma, said: “We are delighted to have Paul join the team as he brings a very distinct and important set of skills relating to operations to the management team.
“Paul will no doubt be a great addition to the team and will play a significant role in overseeing and supporting client projects across both of our sites.”
Bradley added: “As soon as I became aware of the opportunity at SCM Pharma, I was immediately interested as I’d heard very good things about the company’s set-up, vision and its willingness to invest in people, technology and facilities.
“I am very excited by the prospect of working closely with the team and clients to develop and deliver technically challenging products that will benefit all stakeholders and improve patient health.”
Related Content
SCM Pharma unveils formulation development business
UK contract manufacturer SCM Pharma has set up a formulation development business, thanks to a …
SCM wins contract to make high-potency cancer drug
UK contract manufacturing organisation SCM Pharma has been awarded a contract to make commercial supplies …
Pharma manufacturing news in brief
Facility updates from Bristol-Myers Squibb, WuXi PharmaTech, Quotient Clinical, CSM GlobalPharma and SCM Pharma, plus …
